1. Italy Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Safilo Group S.p.A.

Safilo Group S.p.A.

SAFLY
Safilo Group S.p.A.US flagOther OTC
3.76
USD
- -
- -
1.13BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
20.24
21.06
22.79
22.31
18.43
15.2
6.14
5.66
6.5
5.21
4.99
4.81
4.75
22.85
Basic EPS, GAAP
0.28
0.7
-0.94
-2.53
-4.48
-0.54
-2.15
-0.53
0.14
0.26
-0.12
0.11
0.23
-0.94
Free Cash Flow per Basic Share
0.58
-0.21
1.19
0.65
-1.27
-0.34
0.02
-0.12
0.03
-0.02
0.18
0.31
0.39
1.2
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
0.01
- -
- -
- -
- -
- -
Book Value per Share
6.52
8.7
9.13
6.91
0.86
1.09
-1.65
-3.27
-2.45
-1.37
1.71
1.87
1.76
9.15
Tangible Book Value per Share
4.72
6.01
6.28
6.42
4.42
6.04
1.92
0.05
1.28
1.31
1.24
1.24
1.24
6.3
Basic Weighted Avg Shares
55
56
56
56
56
60
153
138
149
207
205
206
207
56
Sales/Revenue/Turnover
1,122
1,179
1,279
1,253
1,035
911
939
780
970
1,077
1,025
993
983
1,279
Operating Margin (%)
7.62
7.05
4.76
3.75
- -
1.75
-1.84
-9.8
1.63
3.5
-0.34
2.87
4.79
4.87
Depreciation Expense
37
35
41
47
42
48
77
59
53
48
55
40
38
41
Net Income, GAAP
16
39
-53
-142
-252
-32
-328
-73
21
54
-25
22
49
-53
Effective Tax Rate (%)
68.09
39.17
- -
- -
- -
- -
- -
- -
42.49
18.38
- -
31.2
28.01
149.49
Profit Margin (%)
1.38
3.31
-4.12
-11.34
-24.3
-3.56
-34.96
-9.35
2.19
5.03
-2.41
2.24
4.95
-4.12
Working Capital
249
277
278
274
184
169
233
192
251
284
259
233
186
278
LT Debt
191
176
133
137
142
- -
110
278
165
152
118
90
58
133
Total Equity
846
974
999
873
533
646
342
182
366
439
396
427
403
999
Return on Invested Capital (%)
2.46
4.35
- -
- -
- -
- -
- -
- -
1.72
5.12
- -
3.48
6.41
9.54
Return on Capital (%)
2.97
6.54
- -
- -
- -
- -
- -
- -
-26.05
-63.86
- -
5.64
10.81
4.56
Return on Common Equity (%)
4.2
9.21
-10.56
-31.58
-115.31
-57.13
- -
- -
- -
- -
- -
6.05
12.98
-10.56

Capital Structure

FRC

•

in mil. unless spec.
Jun'15
Sep'15
Dec'15
ST Debt
60
48
44
LT Borrowings
130
131
133
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
112
112
112
Market Capitalization
754
744
668

Working Capital

FRC

•

in mil. unless spec.
Jun'15
Sep'15
Dec'15
Total Current Assets
663
619
640
Cash, Cash Equivalents & STI
81
84
88
Accounts Receivable, Net
280
228
244
Inventories
248
255
254
Total Current Liabilities
369
330
362
Payables & Accruals
- -
- -
- -
ST Debt
60
48
44
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1.09%
22.63%
-5.71%
Free Cash Flow
-248.03%
-270.47%
25.72%
Net Income, GAAP
80.09%
-38.48%
118.15%
Sales/Revenue/Turnover
-1.88%
5.28%
-0.99%
Total Cash Common Dividend
- -
- -
-62.52%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1,025
2024
- -
- -
- -
- -
993
2025
- -
- -
- -
- -
983

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.12
2024
- -
- -
- -
- -
0.11
2025
- -
- -
- -
- -
0.23

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Angelo Trocchia
Full Time Employees
3,352
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
Settima Strada 15 Padua PD Italy 35129
IPO Date
Apr 3, 2013
CIK
0001538028
Website
safilogroup.com
Similar Companies
Menicon Co Ltd (MECNY)
Sysmex Corporation (SSMXF)
Reflect Scientific, Inc. (RSCF)
I.ceram S.A. (ALICR.PA)
iZafe Group AB (publ) (IZAFE-B.ST)
MOG Holdings Limited (1942.HK)
Business
Safilo Group S.p.A. Safilo Group S.p.A. designs, produces and distributes sunglasses, prescription frames, sports eyewear, goggles and helmets worldwide through its own brands and licensed brands; its core own brands include Carrera, Smith, Polaroid and Blenders Eyewear, while its licensed portfolio encompasses fashion luxury names such as Boss, Carolina Herrera, Etro, Isabel Marant, Missoni, Moschino and Victoria Beckham (distributed from January 1, 2026), lifestyle brands including Dsquared2, Eyewear by David Beckham, Marc Jacobs, Levi's, Tommy Hilfiger, Kate Spade New York and Fossil, and sports offerings from Under Armour; the company operates five international design studios in Padua, Milan, New York, Hong Kong and Portland, three wholly owned production facilities, three main distribution centers in Padua, Denver and Hong Kong, a network of subsidiaries in 40 countries and distribution partners in 70 additional countries reaching approximately 100,000 points of sale including eyecare retailers, chains, department stores, boutiques and sporting goods stores. Founded in 1934 when Guglielmo Tabacchi acquired an eyewear facility dating back to 1878 in Calalzo di Cadore, Italy, the company is headquartered in Padua, Veneto, Italy, and employs over 3,800 people while maintaining more than 145 years of eyewear manufacturing tradition with a focus on Italian design, innovation, sustainability and digital transformation through B2B and B2C platforms like You&Safilo. In recent developments, Safilo Group S.p.A. secured a perpetual license for Eyewear by David Beckham in May 2024, elevating own brands to approximately 50 percent of sales; renewed key licenses including Missoni until 2029, Marc Jacobs until 2031, Tommy Hilfiger, Kate Spade, Boss, Hugo and others through 2030-2031, and signed a ten-year global eyewear licensing agreement with Victoria Beckham; formed a partnership with Spaarkly in February 2024 for augmented reality tools like Virtual Try-On, had short-term science-based sustainability targets validated by SBTi, renewed agreements with Kering Eyewear until 2029, Dsquared2, Carolina Herrera and Under Armour, sold Lenti Srl, launched a shares purchase programme and concluded its 2024 share buyback on November 22, 2024.

Company News

APIChat

  • seekingalpha.com

    Safilo Group S.p.A. (SAFLY) Q1 2026 Sales/Trading Call Transcript

  • seekingalpha.com

    Safilo Group S.p.A. (SAFLY) Q4 2025 Earnings Call Transcript